ClinConnect ClinConnect Logo
Search / Trial NCT06562010

Evaluating the Efficacy of Culturally Adapted iCT-SAD

Launched by UNIVERSITI PUTRA MALAYSIA · Aug 17, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a specially adapted online therapy designed to help people in Pakistan who struggle with Social Anxiety Disorder (SAD). The therapy, called Internet-delivered Cognitive Therapy for Social Anxiety Disorder (iCT-SAD), aims to reduce feelings of anxiety in social situations. The researchers want to see how effective this version of therapy is for people living in Pakistan who can communicate in Urdu.

To participate in the trial, individuals need to be between 18 and 75 years old, have a confirmed diagnosis of Social Anxiety Disorder, and have regular access to the internet. It's important that they are not currently receiving any other type of structured therapy for their anxiety. Unfortunately, people with certain mental health conditions, such as bipolar disorder or active suicidal thoughts, will not be eligible to join. Participants can expect to engage with the therapy online, and it will be tailored to fit cultural elements relevant to them. The study is not yet recruiting participants, but it represents an opportunity for those looking for help with social anxiety.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Primary diagnosis of SAD based on the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)
  • Aged 18-75 years
  • Regular, access to an appropriate internet device
  • Resident of Pakistan and can write and speak Urdu
  • Participants not currently undertaking other structured psychological therapy during the trial
  • Exclusion Criteria:
  • Current psychosis, bipolar disorder, antisocial personality disorder, or alcohol/substance use disorder
  • Active suicidal ideation with intent or plan
  • Previously received CT or cognitive behavioral therapy for SAD

About Universiti Putra Malaysia

Universiti Putra Malaysia (UPM) is a prestigious research university located in Malaysia, renowned for its commitment to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, UPM leverages its extensive academic resources and expertise to conduct rigorous research aimed at improving patient outcomes and contributing to the global body of medical knowledge. The university fosters collaboration among multidisciplinary teams, ensuring that its clinical trials adhere to the highest ethical and regulatory standards while addressing critical health challenges. Through its initiatives, UPM plays a vital role in translating scientific findings into practical applications that benefit society.

Locations

Patients applied

0 patients applied

Trial Officials

MUHAMMAD ARSHED, PhD

Principal Investigator

University of Lahore

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported